These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15974997)

  • 1. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.
    Cerqueira NM; Pereira S; Fernandes PA; Ramos MJ
    Curr Med Chem; 2005; 12(11):1283-94. PubMed ID: 15974997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.
    Cerqueira NM; Fernandes PA; Ramos MJ
    Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of thiols by ribonucleotide reductase.
    Holmgren A; Sengupta R
    Free Radic Biol Med; 2010 Dec; 49(11):1617-28. PubMed ID: 20851762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.
    Pereira S; Fernandes PA; Ramos MJ
    J Comput Chem; 2004 Jul; 25(10):1286-94. PubMed ID: 15139041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and mechanism of ribonucleotide reductases.
    Kolberg M; Strand KR; Graff P; Andersson KK
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):1-34. PubMed ID: 15158709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase.
    Iman M; Khansefid Z; Davood A
    Recent Pat Anticancer Drug Discov; 2016; 11(4):461-468. PubMed ID: 27670694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
    Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase inhibitors and future drug design.
    Shao J; Zhou B; Chu B; Yen Y
    Curr Cancer Drug Targets; 2006 Aug; 6(5):409-31. PubMed ID: 16918309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
    Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
    Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
    Li J; Zheng LM; King I; Doyle TW; Chen SH
    Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleotide reductase: a mechanistic portrait of substrate analogues inhibitors.
    Perez MA; Cerqueira NM; Fernandes PA; Ramos MJ
    Curr Med Chem; 2010; 17(26):2854-72. PubMed ID: 20858168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleotide reductase: Implications of thiol S-nitrosylation and tyrosine nitration for different subunits.
    Chakraborty S; Mukherjee P; Sengupta R
    Nitric Oxide; 2022 Oct; 127():26-43. PubMed ID: 35850377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast Sml1, a protein inhibitor of ribonucleotide reductase.
    Chabes A; Domkin V; Thelander L
    J Biol Chem; 1999 Dec; 274(51):36679-83. PubMed ID: 10593972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of antimicrobial ribonucleotide reductase inhibitors by screening in microwell format.
    Tholander F; Sjöberg BM
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9798-803. PubMed ID: 22665797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ribonucleotide reductase inhibitors: a review on structure activity relationships.
    Moorthy NS; Cerqueira NM; Ramos MJ; Fernandes PA
    Mini Rev Med Chem; 2013 Nov; 13(13):1862-72. PubMed ID: 24032510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical study on the inhibition of ribonucleotide reductase by 2'-mercapto-2'-deoxyribonucleoside-5'-diphosphates.
    Pereira S; Fernandes PA; Ramos MJ
    J Am Chem Soc; 2005 Apr; 127(14):5174-9. PubMed ID: 15810852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.
    Plamthottam S; Sun D; Van Valkenburgh J; Valenzuela J; Ruehle B; Steele D; Poddar S; Marshalik M; Hernandez S; Radu CG; Zink JI
    J Biol Inorg Chem; 2019 Aug; 24(5):621-632. PubMed ID: 31250199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme ribonucleotide reductase: unraveling an enigmatic paradigm of enzyme inhibition by furanone derivatives.
    Cerqueira NM; Fernandes PA; Ramos MJ
    J Phys Chem B; 2006 Oct; 110(42):21272-81. PubMed ID: 17048956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity.
    Manfredini S; Solaroli N; Angusti A; Nalin F; Durini E; Vertuani S; Pricl S; Ferrone M; Spadari S; Focher F; Verri A; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2003 Jul; 14(4):183-94. PubMed ID: 14582847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.